MenQuadfi (Meningococcal (Groups A, C, Y, W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine)

Type: vaccine

Status: FDA Approved

Developer: Sanofi Pasteur

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026